Pfizer
PFE
$23.97
Share price
0.38%
Change (1 day)
-15.48%
Change (1 year)
Categories
Pfizer Inc., is a global pharmaceutical company headquartered in New York City, New York, United States. It was founded by Charles Pfizer from Ludwigsburg. Pfizer is the second largest pharmaceutical company in the world after Roche, followed by Novartis.
P/S ratio for Pfizer (PFE)
P/S ratio as of June 2025 (TTM): 2.18
According to Pfizer's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.50. At the end of 2025 the company had a P/S ratio of 2.29.
P/S ratio history for Pfizer from 2001 to 2025
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2025 | 2.29 | -3.46% |
| 2024 | 2.37 | -13.61% |
| 2023 | 2.74 | -4.27% |
| 2022 | 2.87 | -29.87% |
| 2021 | 4.09 | -27.74% |
| 2020 | 5.66 | 35.01% |
| 2019 | 4.19 | -9.93% |
| 2018 | 4.65 | 13.21% |
| 2017 | 4.11 | 10.12% |
| 2016 | 3.73 | -8.56% |
| 2015 | 4.08 | 3.29% |
| 2014 | 3.95 | 3.97% |
| 2013 | 3.80 | 18.43% |
| 2012 | 3.21 | 27.96% |
| 2011 | 2.51 | 20.22% |
| 2010 | 2.09 | -28.95% |
| 2009 | 2.94 | 18.71% |
| 2008 | 2.47 | -22.1% |
| 2007 | 3.17 | -16.79% |
| 2006 | 3.81 | 9.77% |
| 2005 | 3.47 | -9.19% |
| 2004 | 3.83 | -36.2% |
| 2003 | 6.00 | -3.73% |
| 2002 | 6.23 | -19.84% |
| 2001 | 7.77 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Merck MRK | 3.11 | 42.35% | 🇺🇸 USA |
 Johnson & Johnson JNJ | 4.03 | 84.92% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 2.00 | -8.24% | 🇺🇸 USA |
 Eli Lilly LLY | 14.0 | 540.46% | 🇺🇸 USA |
 Novartis NVS | 4.31 | 97.67% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | 1.92 | -12.02% | 🇬🇧 UK |
 Amgen AMGN | 4.56 | 108.95% | 🇺🇸 USA |
 Abbott Laboratories ABT | 5.46 | 150.46% | 🇺🇸 USA |
 AstraZeneca AZN | 3.99 | 82.93% | 🇬🇧 UK |